Company Description
Optimi Health (NASDAQ: OPTH) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $32.1M, ranking #6,022 among all listed U.S. companies by market cap.
OPTH stock has declined 6.1% over the past year. Shares last traded at $5.71.
This page provides a comprehensive overview of OPTH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Optimi Health (OPTH) stock last traded at $5.71, down 1.75% from the previous close. Over the past 12 months, the stock has lost 6.1%. At a market capitalization of $32.1M, OPTH is classified as a micro-cap stock with approximately 5.7M shares outstanding.
OPTH Rankings
Latest News
Optimi Health has 3 recent news articles, with the latest published yesterday. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include offering. View all OPTH news →
SEC Filings
Optimi Health has filed 1 recent SEC filing, including 1 Form SCHEDULE 13G. The most recent filing was submitted on May 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OPTH SEC filings →
Financial Highlights
Upcoming Events
Underwriter warrant expiry
Optimi Health has 1 upcoming scheduled event. The next event, "Underwriter warrant expiry", is scheduled for May 21, 2031 (in 1819 days). 1 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the OPTH stock price.
Short Interest History
Days to Cover History
OPTH Company Profile & Sector Positioning
Optimi Health (OPTH) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the NASDAQ.